Researchers identified the clinical features that distinguished acute lymphoblastic leukemia from juvenile idiopathic arthritis in children with persistent bone or joint pain for at least 1 month.
Researchers assessed the association between oral health, microbial communities and juvenile idiopathic arthritis.
Study researchers aimed to identify undiagnosed cases of arthropathy of Down syndrome (A-DS), time to diagnosis, and clinical, laboratory and radiologic features of A-DS at diagnosis.
Researchers evaluated the role of adenosine deaminase 2 as a novel biomarker of macrophage activation syndrome.
Investigators analyzed the characteristic traits and risk factors of parenchymal lung disease, which has been increasingly associated with systemic juvenile idiopathic arthritis.
Researchers demonstrated the role of an inflammatory subset of CD4 memory cells in patients with juvenile idiopathic arthritis who are in remission and will relapse on anti-TNF withdrawal.
Investigators reviewed recent evidence from literature on effective transitional care for adolescents and young adults with rheumatic musculoskeletal disease and discussed why universal implementation has not yet been achieved.
Researchers highlighted the use of pharmacologic stress cardiovascular magnetic resonance (PSCMR) in specific pediatric cohorts with congenital and acquired heart disease. They also presented 2 cases of patients with Kawasaki disease, in which PSCMR helped in decision making.
Researchers highlighted the clinical factors that reduce the sensitivity of inflammatory markers in the diagnosis of pediatric osteomyelitis.
Researchers evaluated Canadian claims level data to assess the utilization of methotrexate and prednisone in patients with JIA who initiated etanercept therapy.
